“Controlled Release Matrix Formulation of Paliperidone in Concurrence with Regulatory Requirements”, Int. J. Pharm. Sci. Drug Res., vol. 15, no. 4, pp. 426–431, Jul. 2023, doi: 10.25004/IJPSDR.2023.150405.